Variable Outcome of Immunotherapy in Advanced Multiple Cutaneous Squamous Cell Carcinomas in Two Patients with Recessive Dystrophic Epidermolysis Bullosa

Cutaneous squamous cell carcinoma (cSCC) is a major complication of recessive dystrophic epidermolysis bullosa (RDEB) that has high morbidity and mortality rates and unmet therapeutic needs. The aim of this study was to evaluate the molecular pattern of cSCC and the clinical course of immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: TREFZER, Laura, HESS, Maria E., SCHOLTEN, Lena, TECHNAU-HAFSI, Kristin, MEISS, Frank, BOERRIES, Melanie, HAS, Cristina, RAFEI-SHAMSABADI, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica 2023
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292046/
https://www.ncbi.nlm.nih.gov/pubmed/37338146
http://dx.doi.org/10.2340/actadv.v103.4870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292046/
https://www.ncbi.nlm.nih.gov/pubmed/37338146
http://dx.doi.org/10.2340/actadv.v103.4870

Ejemplares similares